Daniil Gataulin

Stock Analyst at Chardan Capital

(0)
# 4573
Out of 5,326 analysts
87
Total ratings
19.70%
Success rate
-18.06%
Average return
Main Sectors:
Top Industries:
19 Stocks
Name Action Price Target Current % Upside Ratings Updated
UBX Unity Biotechnology
Maintains: Buy
4 4
0.99 304.04% 4 Apr 23, 2025
TRML Tourmaline Bio
Initiates Coverage On: Buy
70
17.41 302.07% 1 Apr 23, 2025
ADVM Adverum Biotechnolog...
Maintains: Buy
40 33
2.95 1018.64% 6 Apr 17, 2025
OCS Oculis Holding
Maintains: Buy
28 28
18.05 55.12% 6 Apr 17, 2025
FBRX Forte Biosciences
Maintains: Buy
64 61
6.78 799.71% 4 Apr 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
27 38
14.27 166.29% 1 Apr 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
6 6
0.85 605.88% 4 Mar 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
11 8
0.44 1718.18% 6 Mar 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
52 52
9.22 463.99% 10 Mar 20, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
14 14
8.85 58.19% 5 Mar 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
33 33
6.57 402.28% 10 Mar 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
6 7
0.74 845.95% 10 Mar 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
36 36
6.56 448.78% 3 Feb 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
3 3
1.55 93.55% 8 Feb 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
220 220
2.73 7958.61% 1 Mar 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Jul 25, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Feb 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
22 13
n/a n/a 2 Nov 8, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
5 3
n/a n/a 2 Sep 28, 2022